223 related articles for article (PubMed ID: 36484017)
1. The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia.
Saunders S; Gregory S; Clement MHS; Birck C; van der Geyten S; Ritchie CW
Front Neurol; 2022; 13():1051543. PubMed ID: 36484017
[TBL] [Abstract][Full Text] [Related]
2. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
[TBL] [Abstract][Full Text] [Related]
3. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL
J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920
[TBL] [Abstract][Full Text] [Related]
4. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
Ritchie CW; Molinuevo JL; Truyen L; Satlin A; Van der Geyten S; Lovestone S;
Lancet Psychiatry; 2016 Feb; 3(2):179-86. PubMed ID: 26683239
[TBL] [Abstract][Full Text] [Related]
5. Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET project.
Hawksworth C; Salih F; Cresswell K; Steukers L; Diaz C; Killin L; Pradier L; Bradshaw A; Dawoud D
Front Neurol; 2023; 14():1140722. PubMed ID: 37006486
[TBL] [Abstract][Full Text] [Related]
6. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
[TBL] [Abstract][Full Text] [Related]
7. Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.
Cummings J; Aisen P; Barton R; Bork J; Doody R; Dwyer J; Egan JC; Feldman H; Lappin D; Truyen L; Salloway S; Sperling R; Vradenburg G
J Prev Alzheimers Dis; 2016 Jun; 3(2):114-120. PubMed ID: 28459045
[TBL] [Abstract][Full Text] [Related]
8. The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks.
O'Rourke D; Coll-Padrós N; Bradshaw A; Killin L; Pradier L; Georges J; Dawoud DM; Steukers L; Diaz C
Front Neurol; 2022; 13():994301. PubMed ID: 36408524
[TBL] [Abstract][Full Text] [Related]
9. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
[TBL] [Abstract][Full Text] [Related]
10. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
[TBL] [Abstract][Full Text] [Related]
11. Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer's disease and other neuropsychiatric disorders.
North H; Hofmann-Apitius M; Kas MJH; Marston H; Haas M
Front Neurol; 2023; 14():1174079. PubMed ID: 37521302
[TBL] [Abstract][Full Text] [Related]
12. European Projects for Patients with Dementia and Their Caregivers.
Tsolaki M; Makri M; Tsatali M; Teichmann Β
Adv Exp Med Biol; 2023; 1425():609-618. PubMed ID: 37581834
[TBL] [Abstract][Full Text] [Related]
13. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS).
Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G
EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266
[TBL] [Abstract][Full Text] [Related]
14. The Innovative Medicines Initiative -10 Years of Public-Private Collaboration.
Laverty H; Meulien P
Front Med (Lausanne); 2019; 6():275. PubMed ID: 31850354
[TBL] [Abstract][Full Text] [Related]
15. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
[TBL] [Abstract][Full Text] [Related]
16. Involving research participants in a pan-European research initiative: the EPAD participant panel experience.
Gregory S; Bunnik EM; Callado AB; Carrie I; De Boer C; Duffus J; Fauria K; Forster S; Gove D; Knezevic I; Laquidain A; Pennetier D; Saunders S; Sparks S; Rice J; Ritchie CW; Milne R
Res Involv Engagem; 2020; 6():62. PubMed ID: 33088590
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Functions as Predictors of Alzheimer's Disease Biomarker Status in the European Prevention of Alzheimer's Dementia Cohort.
Terrera GM; Harrison JE; Ritchie CW; Ritchie K
J Alzheimers Dis; 2020; 74(4):1203-1210. PubMed ID: 32144988
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study.
You J; Zhang YR; Wang HF; Yang M; Feng JF; Yu JT; Cheng W
EClinicalMedicine; 2022 Nov; 53():101665. PubMed ID: 36187723
[TBL] [Abstract][Full Text] [Related]
19. The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow.
Lorenzini L; Ingala S; Wink AM; Kuijer JPA; Wottschel V; Dijsselhof M; Sudre CH; Haller S; Molinuevo JL; Gispert JD; Cash DM; Thomas DL; Vos SB; Prados F; Petr J; Wolz R; Palombit A; Schwarz AJ; Chételat G; Payoux P; Di Perri C; Wardlaw JM; Frisoni GB; Foley C; Fox NC; Ritchie C; Pernet C; Waldman A; Barkhof F; Mutsaerts HJMM;
Neuroimage Clin; 2022; 35():103106. PubMed ID: 35839659
[TBL] [Abstract][Full Text] [Related]
20. Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes.
Gregory S; Wells K; Forysth K; Latto C; Szyra H; Saunders S; Ritchie CW; Milne R
Dementia (London); 2018 Nov; 17(8):1045-1054. PubMed ID: 30373458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
